Claims
- 1. A mutant staphylococcal alpha hemolysin polypeptide comprising a heterologous amino acid, wherein said heterologous amino acid binds an analyte and wherein said polypeptide assembles into a heteroheptameric pore assembly in the presence of a plurality of wild type staphylococcal alpha hemolysin polypeptides.
- 2. The polypeptide of claim 1, wherein said heterologous amino acid occupies a position in a transmembrane channel of said heptameric pore assembly.
- 3. The polypeptide of claim 2, wherein said heterologous amino acid projects into the lumen of said transmembrane channel.
- 4. The polypeptide of claim 2, wherein said heterologous amino acid occupies a position in a stem domain of said polypeptide.
- 5. A staphylococcal alpha hemolysin (αHL) polypeptide comprising at least two non-consecutive heterologous amino acids in a stem domain of said polypeptide, wherein each of said heterologous amino acids binds a metal.
- 6. The polypeptide of claim 5, wherein said amino acids occupy two or more of the following positions of SEQ ID NO:1: 111, 113, 115, 117, 119, 121, 123, 125, 127, 129, 131, 133, 135, 137, 139, 141, 143, 145, 147 or 149.
- 7. The polypeptide of claim 5, wherein said amino acids occupy two or more of the following positions of SEQ ID NO:1: 110, 112, 114, 116, 118, 120, 122, 124, 126, 128, 130, 132, 134, 136, 138, 140, 142, 144, 146, 148.
- 8. The polypeptide of claim 5, wherein said polypeptide comprises at least three non-consecutive heterologous amino acids in the stem domain of said polypeptide.
- 9. The polypeptide of claim 5, wherein said polypeptide comprises at least 4 non-consecutive heterologous amino acids in the stem domain of said polypeptide.
- 10. The polypeptide of claim 9, wherein said amino acids occupy positions 123, 125, 133, and 135 of SEQ ID NO:1.
- 11. The polypeptide of claim 10, wherein said polypeptide is 4H.
- 12. The polypeptide of claim 1, wherein said amino acid is selected from the group consisting of Ser Thr, Met, Trp, and Tyr.
- 13. The polypeptide of claim 12, wherein said amino acid is selected from the group consisting of Glu, Asp, Cys, His.
- 14. The polypeptide of claim 13, wherein said amino acid is His.
- 15. A staphylococcal alpha hemolysin (αHL) polypeptide comprising at least two non-consecutive heterologous amino acids in a stem domain of said polypeptide, wherein each of said heterologous amino acids binds an organic molecule.
- 16. The polypeptide of claim 15, wherein said organic molecule is an explosive.
- 17. The polypeptide of claim 15, wherein said amino acids occupy two or more of the following positions of SEQ ID NO:1: 111, 113, 115, 117, 119, 121, 123, 125, 127, 129, 131, 133, 135, 137, 139, 141, 143, 145, 147 or 149.
- 18. The polypeptide of claim 16, wherein said polypeptide is 123W/125W.
- 19. The polypeptide of claim 1, wherein said polypeptide further comprises a second heterologous amino acid at a site distant from said stem domain.
- 20. The polypeptide of claim 19, wherein said second heterologous amino acid is a Cys residue at position 292 of SEQ ID NO:1.
- 21. A heptomeric pore assembly comprising a mutated staphylococcal αHL polypeptide (MUT), wherein said MUT is an analyte-binding αHL polypeptide.
- 22. The pore assembly of claim 21, wherein said pore assembly is a heptamer having the formula WT7-nMUTn, wherein n is greater than zero and less than seven.
- 23. The pore assembly of claim 21, wherein said analyte-binding αHL polypeptide comprises a heterologous amino acid at a position in a transmembrane channel of said pore assembly, wherein said heterologous amino acid binds a metal.
- 24. The pore assembly of claim 21, wherein said pore assembly is a heptamer having the formula WT7-nMn, wherein n is greater than zero and less than seven.
- 25. The pore assembly of claim 17, wherein said analyte-binding αHL polypeptide is 4H.
- 26. The pore assembly of claim 21, wherein said analyte-binding αHL polypeptide is 123W/125W.
- 27. The pore assembly of claim 25, wherein the pore assembly is a heptamer having the formula WT7-n4Hn.
- 28. The pore assembly of claim 27, wherein the pore assembly is a heteroheptamer having the formula WT64H1.
- 29. A digital biosensor device comprising the pore assembly of claim 21.
- 30. The device of claim 29, wherein said analyte-binding αHL polypeptide comprises at least two non-consecutive heterologous amino acids in the stem domain, wherein each of said heterologous amino acids binds a metal.
- 31. The device of claim 29, wherein said analyte-binding αHL polypeptide comprises a chelating molecule in the stem domain of said polypeptide.
- 32. The device of claim 29, wherein said device detects binding of a metal ion to said analyte-binding αHL polypeptide.
- 33. The device of claim 32, wherein said device detects a single channel current.
- 34. The device of claim 32, wherein said device detects a current through two or more channels.
- 35. A method of detecting the presence of an analyte in a test sample, comprising
(a) contacting said sample with the pore assembly of claim 21; and (b) detecting an electrical current in a digital mode through two or more channels, wherein a modulation in current compared to a current measurement in a control sample lacking said analyte indicates the presence of said analyte in said test sample.
- 36. A method of detecting the presence of an analyte in a test sample, comprising
(a) contacting said sample with the pore assembly of claim 21;(b) detecting an electrical current in a digital mode through a single channel, wherein a modulation in current compared to a current measurement in a control sample lacking said analyte indicates the presence of said analyte in said test sample.
- 37. The method of claim 36, wherein said analyte is a metal ion.
- 38. The method of claim 37, wherein said metal ion is Zn(II).
- 39. The method of claim 37, wherein said metal ion is Co(II), Cu(II), Ni(II), or Cd(II).
- 40. A method of identifying an unknown analyte in a mixture of analytes comprising,
(a) contacting said mixture with the pore assembly of claim 21;(b) detecting an electrical current in a digital mode through two or more channels to determine a mixture current signature; (c) comparing said mixture current signature to a standard current signature of a known analyte, wherein a concurrence of said mixture current signature and said standard current signature indicates the identity of said unknown analyte in said mixture.
- 41. The method of claim 40, wherein each of said known and unknown analytes is a metal ion.
- 42. A method of identifying an analyte in a mixture of analytes comprising,
(a) contacting said mixture with the pore assembly of claim 21;(b) detecting a single channel current in a digital mode to determine a mixture current signature; (c) comparing said mixture current signature to a standard current signature of a known analyte, wherein a concurrence of said mixture current signature and said standard current signature indicates the identity of said unknown analyte in said mixture.
- 43. The method of claim 42, wherein each of said unknown and known analytes is a metal ion.
- 44. The method of claim 43, wherein said metal ion is Zn(II).
- 45. The method of claim 43, wherein said metal ion is Co(II), Cu(II), Ni(II), or Cd(II).
STATEMENT AS TO FEDERALLY SPONSORED RESEARCH
[0001] This application claims priority from provisional application 60/053,737, filed Jul. 25, 1997, which is incorporated herein by reference in full.
Government Interests
[0002] This invention was made with U.S. Government support under the Office of Naval Research grant No. N10014-93-1-0962. The government has certain rights in invention.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60053737 |
Jul 1997 |
US |
Continuations (1)
|
Number |
Date |
Country |
Parent |
09122583 |
Jul 1998 |
US |
Child |
09784985 |
Feb 2001 |
US |